首页> 外国专利> In vitro expression of the HCV ARFP/F-core‘coding open reading frame

In vitro expression of the HCV ARFP/F-core‘coding open reading frame

机译:HCV ARFP / F-core′编码开放阅读框的体外表达

摘要

A method of producing and purifying an HCV polypeptide, wherein the method comprises providing host cells containing an expression vector comprising a polynucleotide operably linked to expression control elements, wherein the polynucleotide is an open reading frame that overlaps the core gene in the +1 frame (core+1 ORF) of HCV, which encodes an HCV polypeptide (core+1) of 16/17 kDa or 12.5 kDa is provided. The host cells can be cultured under conditions that express the HCV polypeptide (core+1) and that suppress the expression of HCV core polypeptide. The cells can be cultured in the presence of a proteosome inhibitor. An HCV polypeptide (core+1) produced by the method and an antibody that immunologically reacts with the polypeptide are provided. Isolated nucleic acids, vectors, and host cells comprising an HCV IRES element comprising core+1 sequences between nucleotides 345 and 591 are also disclosed.
机译:一种产生和纯化HCV多肽的方法,其中该方法包括提供宿主细胞,该宿主细胞包含表达载体,该表达载体包含可操作地连接至表达控制元件的多核苷酸,其中该多核苷酸是在+1框中与核心基因重叠的开放阅读框(提供了编码16/17 kDa或12.5 kDa的HCV多肽(core + 1)的HCV的core + 1 ORF)。宿主细胞可以在表达HCV多肽(核心+1)并且抑制HCV核心多肽表达的条件下培养。可以在蛋白体抑制剂的存在下培养细胞。提供了通过该方法产生的HCV多肽(核心+1)和与该多肽发生免疫反应的抗体。还公开了包含HCV IRES元件的分离的核酸,载体和宿主细胞,所述HCV IRES元件包含核苷酸345和591之间的核+1序列。

著录项

  • 公开/公告号US2006166320A1

    专利类型

  • 公开/公告日2006-07-27

    原文格式PDF

  • 申请/专利权人 PENELOPE MAVROMARA;NIKI VASSILAKI;

    申请/专利号US20050240595

  • 发明设计人 NIKI VASSILAKI;PENELOPE MAVROMARA;

    申请日2005-10-03

  • 分类号C12P21/06;C07H21/02;C12N1/21;C07K14/18;C12N15/74;

  • 国家 US

  • 入库时间 2022-08-21 21:47:16

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号